Blood Cancer

EAA171 / OPTIMUM

STATUS:




    Interactive content above is from the official study record on the National Cancer Institute website, cancer.gov.

    The ECOG-ACRIN Cancer Research Group designed this trial and is conducting it with funding from the National Cancer Institute through its National Clinical Trials Network.

    EAA171 / OPTIMUM (Closed)
    EAA171 / OPTIMUM (Closed)
    EAA171 / OPTIMUM (Closed)
    Advocacy Blog Feature
    View EAA171 / OPTIMUM Record on ClinicalTrials.gov
    Review Other Active Trials
    ECOG-ACRIN Cancer Research Group